TerminatedNot applicableNCT00399893

Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)

Studying Prader-Willi syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Duke University
Principal Investigator
Andrea M Haqq, MD
Duke University
Intervention
Octreotide(drug)
Enrollment
5 enrolled
Eligibility
5-21 years · All sexes
Timeline
20062010

Study locations (1)

Collaborators

National Institutes of Health (NIH) · National Center for Research Resources (NCRR) · Novartis

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00399893 on ClinicalTrials.gov

Other trials for Prader-Willi syndrome

Additional recruiting or active studies for the same condition.

See all trials for Prader-Willi syndrome

← Back to all trials